2012•Journal of the National Comprehensive Cancer NetworkOpen access
Neuroendocrine Tumors
Matthew H. Kulke, Al B. Benson, Emily K. Bergsland, Jordan Berlin, Lawrence S. Blaszkowsky, Michael A. Choti, Orlo H. Clark, Gerard M. Doherty, James D. Eason, Lyska L. Emerson, Paul F. Engstrom, Whitney Goldner, Martin J. Heslin, Fouad Kandeel, Pamela L. Kunz, Boris W. Kuvshinoff, Jeffrey F. Moley, Venu G. Pillarisetty, Leonard B. Saltz, D.E. Schteingart, Manisha H. Shah, Stephen Shibata, Jonathan Strosberg, Jean‐Nicolas Vauthey, Rebekah R. White, James C. Yao, Deborah A. Freedman-Cass, Mary A. Dwyer
Open full text 186 citations
Abstract
Neuroendocrine tumors comprise a broad family of tumors, the most common of which are carcinoid and pancreatic neuroendocrine tumors. The NCCN Neuroendocrine Tumors Guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine tumors. Most of the recommendations pertain to well-differentiated, low- to intermediate-grade tumors. This updated version of the NCCN Guidelines includes a new section on pathology for diagnosis and reporting and revised recommendations for the surgical management of neuroendocrine tumors of the pancreas.
Open-access reader